OSKIRA-4: a phase IIb randomised, placebo-controlled study of the efficacy and safety of fostamatinib monotherapy. by Taylor, P, Genovese, M, Greenwood, M, Ho, M, Nasonov, E, Oemar, B, Stoilov, R, Vencovsky, J, Weinblatt, M